Chronic Kidney Disease: Global Mortality Rate
- Here's a breakdown of the key details from the provided text, focusing on the management of cardiometabolic disease and chronic kidney disease (CKD):
- * Integrated Approach: Effective CKD treatment requires addressing upstream cardiometabolic health, not just focusing on CKD-specific therapies after diagnosis.
- * Presentation: The information was presented at ASN Kidney Week (November 5-9, 2025, Houston) by mark PB, et al.
Here’s a breakdown of the key details from the provided text, focusing on the management of cardiometabolic disease and chronic kidney disease (CKD):
Key Takeaways:
* Integrated Approach: Effective CKD treatment requires addressing upstream cardiometabolic health, not just focusing on CKD-specific therapies after diagnosis.
* Early Intervention: Screening for CKD is important, but improving cardiometabolic health and dietary habits (specifically, lower sodium intake) are crucial before CKD progresses.
* Therapies as a Start: While therapies like renin-angiotensin system blockade and SGLT2 inhibitors are helpful, they are not the complete solution.
* Funding & Disclosures: The study was funded by the Gates Foundation, NIH/NIDDK, and Wellcome. Dr. Mark has financial ties to several pharmaceutical companies (AstraZeneca, Bayer, Boehringer Ingelheim, etc.) through consulting fees,lecture fees,and research support.
Who to Contact:
* Patrick B. Mark, MB, ChB, PhD: nephrology@healio.com
Source Information:
* Presentation: The information was presented at ASN Kidney Week (November 5-9, 2025, Houston) by mark PB, et al. (FR-OR093).
Healio AI Promotion:
* The article also promotes Healio AI, a tool that can answer clinical questions using a knowledge base including PubMed, trials, guidelines, and Healio’s news coverage.
